Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction

BACKGROUND: Convalescent plasma (CP) therapy for coronavirus disease (COVID‐19) provides virus‐neutralizing antibodies that may ameliorate the outcome of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections. The effectiveness of CP likely depends on its antiviral neutralizing pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamikanra, Abigail, Nguyen, Dung, Simmonds, Peter, Williams, Sarah, Bentley, Emma M., Rowe, Cathy, Otter, Ashley David, Brooks, Tim, Gilmour, Kimberly, Mai, Annabelle, Dadhra, Jusvinder, Csatari, Mabel, Ziyenge, Sheba, Oliveira, Marta, Ploeg, Rutger, Tsang, Pat, Zambon, Maria, Gopal, Robin, Xiao, Julie Huiyuan, Townsend, Alain, Roberts, David, Harvala, Heli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447482/
https://www.ncbi.nlm.nih.gov/pubmed/34342366
http://dx.doi.org/10.1111/trf.16600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447482/
https://www.ncbi.nlm.nih.gov/pubmed/34342366
http://dx.doi.org/10.1111/trf.16600

Ejemplares similares